Inhalation of activated protein C: A possible new adjunctive intervention in acute respiratory distress syndrome

Biologics: Targets and Therapy

Volumn 1, Issue 4, 2007, Pages 465-472

  Heslet, Lars ^a   Andersen, Jakob Steen ^a   Sengeløv, Henrik ^b   Dahlbäck, Björn ^c   Dalsgaard Nielsen, Jorgen ^d  

^a Department of Intensive Care ITA 4131 ^*  (Denmark)

^b Rigshospitalet   (Denmark)

^c LUND UNIVERSITY   (Sweden)

^d GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Activated protein c inhalation; Ards; Pulmonary hemostasis; Pulmonary host defense

Indexed keywords

EID: 65849197141     PISSN: 11775475     EISSN: 11775491     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Abraham E. 2003. Neutrophils and acute lung injury. Crit Care Med, 31: S195-S199.
2. Baleeiro CE, Christensen PJ, Morris SB, et al. 2006. GM-CSF and the impaired pulmonary innate immune response following hyperoxic stress. Am J Physiol Lung Cell Mol Physiol, 291:L1246-55.
3. Bastarache JA, Wang L, Geiser T, et al. 2007. The alveolar epithelium can initiate the extrinsic coagulation cascade through expression of tissue factor. Thorax, 62:608-16.
4. Bernard GR, Ely EW, Wright TJ, et al. 2001a. Safety and dose relationship of recombinant human activated protein C for coagulopathy in severe sepsis. Crit Care Med, 29:2051-9.
5. Bernard GR, Vincent JL, Laterre PF, et al. 2001b. Recombinant human protein C Worldwide Evaluation in Severe Sepsis (PROWESS) study group. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med, 344:699-709.
6. Choi G, Hofstra JJ, Roelofs JJ, et al. 2007. Recombinant human activated protein C inhibits local and systemic activation of coagulation without influencing inflammation during Pseudomonas aeruginosa pneumonia in rats. Crit Care Med, 35:1362-8.
7. Dahlback B, Villoutreix BO. 2005. Regulation of blood coagulation by the protein C anticoagulant pathway: novel insights into structure-function relationships and molecular recognition. Arterioscler Thromb Vasc Biol, 25:1311-20.
8. Doreen E. Wesche-Soldato, Ryan Z, et al. 2007. The apoptotic pathway as a therapeutic target in sepsis. Curr Drug Targets, 8(4):493-500.
9. Dubus JC, Vecellio L, De Monte M, et al. 2005. Aerosol deposition in neonatal ventilation. Pediatr Res, 58:10-14.
10. Esmon CT. 2006. Inflammation and the activated protein C anticoagulant pathway. Semin Thromb Hemost, Suppl 1:49-60.
11. Feistritzer C, Mosheimer BA, Sturn DH, et al. 2006. Endothelial protein C receptor-dependent inhibition of migration of human lymphocytes by protein C involves epidermal growth factor receptor. J Immunol, 176:1019-25.
12. Fujimoto H, Gabazza EC, Hataji O, et al. 2003. Thrombin-activatable fibrinolysis inhibitor and protein C inhibitor in interstitial lung disease. Am J Respir Crit Care Med, 167:1687-94.
13. Girard TD, Bernard GR. 2007. Mechanical ventilation in ARDS: a state-of-the-art review Chest, 131:921-9.
14. Griffin JH, Fernández JA, Gale AJ, et al. 2007. Activated protein C. J Thromb Haemost, 5(Suppl 1):73-80
15. Grissell TV, Chang AB, Gibson PG. 2007. Reduced toll-like receptor 4 and substance P gene expression is associated with airway bacterial colonization in children. Pediatr Pulmonol, 42:380-5.
16. Günther A, Mosavi P, Heinemann S, et al. 2000. Alveolar fibrin formation caused by enhanced procoagulant and depressed fibrinolytic capacities in severe pneumonia: comparison with the acute respiratory distress syndrome. Am J Respir Crit Care Med, 161:454-62.
17. Hancock WW, Grey ST, Hau L, et al. 1995. Binding of activated protein C to a specific receptor on human mononuclear phagocytes inhibits intracellular calcium signaling and monocyte-dependent proliferative responses. Transplantation, 60:1525-32.
18. Krowka MJ, Rosenow EC 3rd, Hoagland HC. 1985. Pulmonary complications of bone marrow transplantation. Chest, 87:237-46.
19. Maris NA, Vos AF, Bresser P, et al. 2007. Salmeterol enhances pulmonary fibrinolysis in healthy volunteers. Crit Care Med, 35:57-63.
20. Mosnier LO, Zlokovic BV, Griffin JH. 2007. The cytoprotective protein C pathway. Blood, 109:3161-72.
21. Nick JA, Coldren CD, Geraci MW, et al. 2004. Recombinant human activated protein C reduces human endotoxin-induced pulmonary inflammation via inhibition of neutrophil chemotaxis. Blood, 104:3878-85.
22. Oette SM, Gedeon CR, Kowalczyk TH, et al. 2004. Aerosols of compacted DNA nanoparticles retain structural integrity and biological activity. Mol Ther, 9:S190.
23. Opal SM, and Esmon CT. 2003. Bench-to-bedside review: functional relationships between coagulation and the innate immune response and their respective roles in the pathogenesis of sepsis. Crit Care, 7(1):23-38.
24. Pène F, Aubron C, Azoulay E et al. 2006. Outcome of critically ill allogeneic hematopoietic stem-cell transplantation recipients: a reappraisal of indications for organ failure supports. J Clin Oncol, 24:643-9.
25. Sallenave JM, Donnelly SC, Grant IS. 1999. Secretory leukocyte proteinase inhibitor is preferentially increased in patients with acute respiratory distress syndrome. Eur Respir J, 13:1029-36.
26. Schultz MJ, Haitsma JJ, Zhang H, et al. 2006. Pulmonary coagulopathy as a new target in therapeutic studies of acute lung injury or pneumonia a review. Crit Care Med, 34:871-7.
27. Shetty S, Rao GN, Cines DB, et al. 2006. Urokinase induces activation of STAT3 in lung epithelial cells. Am J Physiol Lung Cell Mol Physiol, 291:772-80.
28. Shorr AF, Moores LK, Edenfield WJ, et al. 1999. Mechanical ventilation in hematopoietic stem cell transplantation: can we effectively predict outcomes? Chest, 116:1012-18.
29. Slofstra SH, Groot AP, Maris NA, et al. 2006. Inhalation of activated protein C inhibits endotoxin-induced pulmonary inflammation in mice indepen-dent of neutrophil recruitment. Br J Pharmacol, 149:740-6.
30. Stephenson DA, Toltl LJ, Beaudin S, et al. 2006. Modulation of monocyte function by activated protein C, a natural anticoagulant. J Immunol, 177:2115-22.
31. Sturn DH, Kaneider NC, Feistritzer C, et al. 2003. Expression and function of the endothelial protein C receptor in human neutrophils. Blood, 102:1499-505.
32. Suter PM. 2006. Lung Inflammation in ARDS-Friend or Foe? Editorial. N Engl J Med, 354:1739-41.
33. The National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network. 2006. Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome. N Engl J Med, 354:1671-84.
34. van der Poll T, Levi M, Nick JA, et al. 2005.Activated protein C inhibits local coagulation after intrapulmonary delivery of endotoxin in humans. Am J Respir Crit Care Med, 171:1125-8.
35. Wang L, Bastarache JA, Wickersham N, et al. 2007. Novel role of the human alveolar epithelium in regulating intra-alveolar coagulation. Am J Respir Cell Mol Biol, 36:497-503.
36. Ware LB, Fang X, Matthay MA. 2003. Protein C and thrombomodulin in human acute lung injury. Am J Physiol Lung Cell Mol Physiol, 285: L514-L521.
37. Watkins TR, Chien JW, Crawford SW. 2005. Graft versus host-associated pulmonary disease and other idiopathic pulmonary complications after hematopoietic stem cell transplant. Semin Respir Crit Care Med, 26:482-89.
38. Wheeler AP, Bernard GR. 2007. Acute lung injury and the acute respiratory distress syndrome: a clinical review. Lancet, 369(9572):1553-64.
39. Yuda H, Adachi Y, Taguchi O, et al. 2004. Activated protein C inhibits bronchial hyperresponsiveness and Th2 cytokine expression in mice. Blood, 103:2196-204.